Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

• click to rate

  Posted by Two Blokes Jun 17 - Filed in Stock - 8 views
  
  Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.